Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Primary TMAs | |
Shiga toxin-producing E. Coli-associated HUS | |
Thrombotic thrombocytopenic purpura | |
Atypical HUS or complement-mediated | |
Secondary TMAs | |
Infections including viral, fungal, and bacterial | |
Drugs including immunosuppressants and chemotherapeutic agents | |
Autoimmune diseases | |
Malignant hypertension | |
Malignancy | |
Metabolic defects | |
Pregnancy | |
Transplantation, both hematopoietic stem cell transplantation and solid organ transplantation | |
Disseminated intravascular coagulation | |
Radiation |
Recurrent TMA, rare (5%-10% of cases) |
Mutations in complement regulatory factor genes [e.g., factor H, factor I, membrane cofactor protein, etc.] |
Mutations in complement genes (e.g., C3) |
TMA associated with autoantibodies (anti-factor H antibodies, anti-ADAMTS13 antibodies, antiphospholipid antibodies) |
TMA associated with autoimmune diseases (scleroderma and systemic lupus erythematosus) |
De-novo TMA, common (90%-95% of cases) |
Associated with the type of donor and organ procurement procedure, e.g. Ischemia reperfusion injury |
Drugs |
I: Calcineurin inhibitors-associated TMA |
II: Mammalian target of rapamycin inhibitors-associated TMA |
Antibody-mediated rejection associated TMA |
Infection-associated TMA |
I: Viral, e.g. hepatitis C virus, parvovirus B19, and cytomegalovirus) |
II: Fungal |
III: Bacterial |
Other rare causes, such as malignancy, other drugs, and pregnancy |
Active lesions | ||
1 Glomerular lesions (Light microscopy): | ||
Intraluminal thrombi | ||
Endothelial swelling or denudation | ||
Endothelial swelling or denudation | ||
Subendothelial space widening (bloodless glomeruli) | ||
Mesangiolysis | ||
Microaneurysms | ||
2 Arteriolar lesions: | ||
Intraluminal thrombi | ||
Endothelial swelling or denudation | ||
Intramural fibrin | ||
Fragmented red blood cells | ||
3 Arterial lesions: | ||
Intraluminal thrombi | ||
Intimal edema | ||
Myxoid intimal swelling | ||
Myocyte necrosis | ||
Intramural fibrin | ||
Fragmentation of red blood cells | ||
Chronic lesions | ||
1 Glomerular lesions (Light microscopy): | ||
Double contours of peripheral capillary walls, with variable mesangial interposition | ||
2 Arteriolar lesions: | ||
Hyaline deposits | ||
3 Arterial lesions: | ||
Fibrous intimal thickening with concentric lamination (onion-skining) |
- Citation: Mubarak M, Raza A, Rashid R, Sapna F, Shakeel S. Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra. World J Transplant 2024; 14(1): 90277
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/90277.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.90277